Amedeo Smart

Free Medical Literature Service

 

Amedeo

Depression
  Free Subscription

Articles published in
Can J Psychiatry
    August 2026
  1. FREEDMAN DE, Oh J, Einstein G, Feinstein A, et al
    Sex Differences in the Neuropsychiatric Symptoms of Multiple Sclerosis: Symptomes neuropsychiatriques de la sclerose en plaques: differences selon le sexe.
    Can J Psychiatry. 2026;71:612-622.
    >> Share

    July 2026
  2. SONG BX, Vieira E, Gallagher D, Diniz BS, et al
    Blood Angiogenesis Markers and Cognition in Older Adults at Risk for Dementia: Marqueurs sanguins de l'angiogenese et cognition chez les personnes agees a risque de demence.
    Can J Psychiatry. 2026;71:519-530.
    >> Share

  3. GEORGE KV, Savoy CD, Layton H, Bieling PJ, et al
    Prevalence of Comorbid Postpartum Depression and Anxiety in Birthing Parents Seeking Treatment for Postpartum Depression: Prevalence de la presence comorbide de la depression et de l'anxiete post-partum chez les parents ayant accouche qui ont consulte
    Can J Psychiatry. 2026 Jul 1:7067437261462698. doi: 10.1177/07067437261462698.
    >> Share

    June 2026
  4. ZHOU C, Fabiano N, Wong S, Hojlund M, et al
    Transcranial Magnetic Stimulation for Bipolar Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials: Stimulation magnetique transcranienne dans les cas de depression bipolaire : une revue systematique et une meta-analyse d'
    Can J Psychiatry. 2026 Jun 4:7067437261457224. doi: 10.1177/07067437261457224.
    >> Share

  5. LEE JJ, Blumberger DM
    Revisiting the Management of Treatment-Resistant Depression.
    Can J Psychiatry. 2026 Jun 3:7067437261456022. doi: 10.1177/07067437261456022.
    >> Share

    May 2026
  6. MEN X, Taylor ZL, Marshe VS, Blumberger DM, et al
    Association Between Venlafaxine Exposure And Treatment Outcomes In Older Adults With Depression: Association entre l'exposition a la venlafaxine et les resultats du traitement chez les personnes agees atteintes de depression.
    Can J Psychiatry. 2026 May 14:7067437261451057. doi: 10.1177/07067437261451057.
    >> Share

  7. BORGHGRAEF D, Sienaert P, Lambrichts S
    Which Residual Symptoms Predict Relapse in major Depression? A Scoping Review: Quels symptomes residuels constituent des predicteurs de rechute de depression majeure? Un examen de la portee.
    Can J Psychiatry. 2026 May 6:7067437261448747. doi: 10.1177/07067437261448747.
    >> Share

  8. ONG D, Ladhar S, Perry T, Carney G, et al
    Rising Escitalopram Use in British Columbia: Is it Rational and Evidence-Informed?
    Can J Psychiatry. 2026;71:406-408.
    >> Share

  9. BAHJI A, Brietzke E, Cooke NCA, Clement F, et al
    The Canadian Network for Mood and Anxiety Treatments Task Force Recommendations for the Use of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplants in Adults With Major Depressive Disorder: Recommandations du Groupe de travail du Resea
    Can J Psychiatry. 2026;71:346-358.
    >> Share

    April 2026
  10. GRANT PL, Drotsky JF, Goldstein AL, George TP, et al
    The Relationship Between Depression and Quality of Life in Children and Adolescents: A Systematic Review: Lien entre depression et qualite de vie chez les enfants et les adolescents : Une revue systematique.
    Can J Psychiatry. 2026 Apr 24:7067437261442375. doi: 10.1177/07067437261442375.
    >> Share

  11. ISKIN SA, Elias GJB, Naheed A, Pinto J, et al
    Capturing Brain Response Patterns to Subcallosal Cingulate Deep Brain Stimulation Using Cycling fMRI: A Proof-of-Concept Study: Acquisition de schemas cerebraux de reponse a la stimulation cerebrale profonde ciblant le cortex cingulaire subgenual a l'
    Can J Psychiatry. 2026;71:277-285.
    >> Share

    March 2026
  12. DINAN TG, Cryan JF
    Faecal Transplants for Bipolar Depression: Moving out of the Periphery?
    Can J Psychiatry. 2026 Mar 5:7067437261428007. doi: 10.1177/07067437261428007.
    >> Share

    February 2026
  13. HALLADAY J, Ji C, Georgiades K, McDonald A, et al
    Changes in Cross-Sectional Associations Between Cannabis Use and Anxiety, Depression, and Suicidality in a Nationally Representative Sample of Canadians From 2012 to 2022: Evolution des relations transversales entre la consommation de cannabis et la d
    Can J Psychiatry. 2026 Feb 26:7067437261420701. doi: 10.1177/07067437261420701.
    >> Share

  14. SWAINSON J, Brietzke E, Khullar A, McIntyre RS, et al
    Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment Models.
    Can J Psychiatry. 2026;71:83-88.
    >> Share

    December 2025
  15. STENGEL C, Schwartzmann B, Chatterjee R, Atluri S, et al
    Modulation of Brain Temporal Complexity During Treatment for Depression: A CAN-BIND-1 Study Report: Modulation de la complexite temporelle du cerveau pendant le traitement de la depression: rapport de l'etude CAN-BIND-1.
    Can J Psychiatry. 2025 Dec 26:7067437251408188. doi: 10.1177/07067437251408188.
    >> Share

    November 2025
  16. OPREA A, Steinman J, Huang G, Soyinka O, et al
    Oral Methods of Microbiota Manipulation for Depression Symptoms: A Systematic Review: Methodes orales de manipulation du microbiote pour traiter les symptomes de depression : Une revue systematique.
    Can J Psychiatry. 2025 Nov 27:7067437251394369. doi: 10.1177/07067437251394369.
    >> Share

  17. FREEDMAN DE, Feinstein A
    Depression in Multiple Sclerosis: A Clinical Primer for Psychiatrists.
    Can J Psychiatry. 2025 Nov 18:7067437251396765. doi: 10.1177/07067437251396765.
    >> Share

  18. MACRYNIKOLA N, Chang S, Torous J
    Emotion Regulation Self-Efficacy as a Mechanism of Alliance and Outcomes in a Brief, Transdiagnostic Digital Mental Health Intervention: L'auto-efficacite de la regulation des emotions en tant que mecanisme d'alliance et de resultats dans une breve in
    Can J Psychiatry. 2025;70:824-833.
    >> Share

    October 2025
  19. GIACOBBE P, Rizvi SJ, Ceniti AK, Tomlinson G, et al
    Deep Brain Stimulation to the Subgenual Cingulate Gyrus for Treatment-Resistant Depression: A Randomized Controlled Trial and 2-Year Long-Term Follow-Up: Stimulation cerebrale profonde du gyrus cingulaire subgenual pour traiter la depression resistant
    Can J Psychiatry. 2025 Oct 31:7067437251369226. doi: 10.1177/07067437251369226.
    >> Share

  20. CHISAMORE N, Kaczmarek ES, Doyle Z, Johnson DE, et al
    Comparing Antidepressant Effects of Psilocybin-Assisted Psychotherapy in Individuals That Were Unmedicated at Initial Screening Versus Individuals Discontinuing Medications for Study Participation: Comparaison des effets antidepresseurs de la psychoth
    Can J Psychiatry. 2025;70:759-767.
    >> Share

  21. DEMAYO MM, Cole J, Sohn MN, Bray SL, et al
    Procognitive Effects of Adjunctive D-Cycloserine to Intermittent Theta-Burst Stimulation in Major Depressive Disorder: Effets procognitifs de la D-cycloserine en traitement complementaire par la stimulation theta-burst intermittente dans le trouble de
    Can J Psychiatry. 2025;70:750-758.
    >> Share

    September 2025
  22. BAHJI A, Tang V, Danilewitz M
    Integrated Management of Co-Occurring Alcohol Use Disorder and Depression: Clinical Approaches for Concurrent Disorders.
    Can J Psychiatry. 2025 Sep 3:7067437251374564. doi: 10.1177/07067437251374564.
    >> Share

    August 2025
  23. MESHKAT S, Lin Q, Tassone VK, Janssen-Aguilar R, et al
    Mental Health Service Type Use and Depressive Symptoms: A Multivariable Analysis of Sociodemographic Correlates: Utilisation des services de sante mentale et symptomes depressifs : Analyse multi-variables des correlats sociodemographiques.
    Can J Psychiatry. 2025;70:611-619.
    >> Share

    July 2025
  24. MAGARBEH L, Elsheikh SSM, Islam F, Marshe VS, et al
    Polygenic Risk Score Analysis of Antidepressant Treatment Outcomes: A CAN-BIND-1 Study Report: Analyse des resultats du traitement antidepresseur a l'aide des scores de risque polygeniques : Rapport sur l'etude CAN-BIND-1.
    Can J Psychiatry. 2025;70:552-564.
    >> Share

  25. ABU-ASHOUR W, Delaney S, Farrell A, Gamble JM, et al
    Incidence of Major Depressive Disorder Relapse and Effectiveness of Pharmacologic and Psychological Interventions in Primary Care: A Systematic Review and Meta-Analysis: Incidence de la rechute du trouble depressif majeur et efficacite des interventio
    Can J Psychiatry. 2025;70:529-551.
    >> Share

    May 2025
  26. NG E, Nestor SM, Rabin JS, Hamani C, et al
    Impact of Comorbid Posttraumatic Stress-Related Symptoms on Repetitive Transcranial Magnetic Stimulation for Depression in Civilians: Incidence des symptomes du trouble de stress post-traumatique (TSPT) comorbide sur la stimulation magnetique transcra
    Can J Psychiatry. 2025 May 30:7067437251342277. doi: 10.1177/07067437251342277.
    >> Share

  27. ASADULLAH H, Abbasi SUAM, Nabi R
    Integrating Mental Health in Perioperative Care: Addressing the Overlooked Impact of Chronic Stress and Depression on Surgical Outcomes.
    Can J Psychiatry. 2025 May 19:7067437251340667. doi: 10.1177/07067437251340667.
    >> Share

  28. NAEEM F, Husain MI, Husain MO, Mutta B, et al
    Feasibility and Acceptability of Online Culturally Adapted Cognitive Behavioural Therapy for Depression and Anxiety in Canadians of South Asian Origin: A Randomized Controlled Trial: Faisabilite et acceptabilite de la therapie cognitivo-comportemental
    Can J Psychiatry. 2025 May 15:7067437251337644. doi: 10.1177/07067437251337644.
    >> Share

  29. LONGMORE A, Anagnostou E, Georgiages S, Jones J, et al
    Predictors of Depressive Symptoms in Autistic Youth-A Longitudinal Study From the Province of Ontario Neurodevelopmental Disorders (POND) Network: Predicteurs des symptomes depressifs chez les jeunes autistes-une etude longitudinale du Reseau des trou
    Can J Psychiatry. 2025;70:372-381.
    >> Share

    April 2025
  30. LAM RW, Rnic K, Nunez JJ, Ho K, et al
    Predicting Relapse of Depressive Episodes During Maintenance Treatment: The Canadian Biomarker Integration Network in Depression (CAN-BIND) Wellness Monitoring in Major Depressive Disorder Study: Predire la rechute d'episodes depressifs pendant le tra
    Can J Psychiatry. 2025 Apr 29:7067437251337603. doi: 10.1177/07067437251337603.
    >> Share

  31. PIAUX C, Bourquin C, Stiefel F
    Depressive Symptoms and Epistemological Approaches: A Qualitative Study Among Psychiatrists: Symptomes depressifs et approches epistemologiques : une etude qualitative aupres de psychiatres.
    Can J Psychiatry. 2025;70:320-327.
    >> Share

    March 2025
  32. DAMA MH, Martin J, Tassone VK, Lin Q, et al
    The Association Between Delayed Sleep-Wake Phase Disorder and Depression Among Young Individuals: A Systematic Review and Meta-Analysis: Association entre le syndrome de retard de phase et la depression parmi les jeunes : revue systematique et meta-an
    Can J Psychiatry. 2025 Mar 24:7067437251328308. doi: 10.1177/07067437251328308.
    >> Share

  33. CHINNA MEYYAPPAN A, Sgarbossa C, Bromley H, Forth E, et al
    The Safety and Efficacy of Microbial Ecosystem Therapeutic-2 in People With Major Depression - A Phase 2, Double-Blind, Placebo-Controlled Study: Clinical Results: Innocuite et efficacite du traitement de l'ecosysteme microbien (met-2) dans la depress
    Can J Psychiatry. 2025 Mar 21:7067437251328270. doi: 10.1177/07067437251328270.
    >> Share

  34. RAE J, Lavigne KM, Sauve G, Lepage M, et al
    Mapping Insight Dimensions and Symptom Dynamics in Schizophrenia: A Data-Driven Network Approach: Cartographie des dimensions d'insight et de la dynamique symptomatique dans la schizophrenie: une approche par reseau fondee sur les donnees.
    Can J Psychiatry. 2025 Mar 21:7067437251329074. doi: 10.1177/07067437251329074.
    >> Share

  35. OSTINELLI EG, Jaquiery M, Liu Q, Elgarf R, et al
    Personalising Antidepressant Treatment for Unipolar Depression Combining Individual Choices, Risks and big Data: The PETRUSHKA Tool: Personnalisation du traitement antidepresseur de la depression unipolaire associant choix individuels, risques et mega
    Can J Psychiatry. 2025 Mar 13:7067437251322399. doi: 10.1177/07067437251322399.
    >> Share

    January 2025
  36. GOKE K, McClintock SM, Mah L, Rajji TK, et al
    Cognitive Outcomes After Transcranial Magnetic Stimulation for the Treatment of Late-Life Depression: Resultats cognitifs apres la stimulation magnetique transcranienne pour le traitement de la depression chez les personnes agees.
    Can J Psychiatry. 2025 Jan 29:7067437251315515. doi: 10.1177/07067437251315515.
    >> Share

    December 2024
  37. MARCHETTI S, Feinstein A
    The Psychological Health of Iranian Citizens Protesting the Actions of Their Country's Morality Police: La sante psychologique des citoyens iraniens qui manifestent contre les actions de la police des moeurs de leur pays.
    Can J Psychiatry. 2024;69:861-868.
    >> Share

    November 2024
  38. ABBASS A, Luyten P, Leichsenring F
    Short-Term Psychodynamic Psychotherapy is the First-Line Option for Depression and Treatment Resistant Depression According to Available Evidence.
    Can J Psychiatry. 2024 Nov 18:7067437241299487. doi: 10.1177/07067437241299487.
    >> Share

    October 2024
  39. MAN LLY, Rotenberg M, Andari S, Wells S, et al
    Eco-Depression and Eco-Anxiety Among Youth: A Sex and Gender Analysis.
    Can J Psychiatry. 2024 Oct 1:7067437241287153. doi: 10.1177/07067437241287153.
    >> Share

    September 2024
  40. BECK K, Young AH
    Commentary on the Canadian Network for Mood and Anxiety Treatments 2023 Clinical Guidelines for Management of Major Depressive Disorder in Adults - Capturing the State of the Art.
    Can J Psychiatry. 2024;69:692-694.
    >> Share

  41. LAM RW, Kennedy SH, Adams C, Bahji A, et al
    Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Reseau canadien pour les traitements de l'humeur et de l'anxiete (CANMAT) 2023 : Mise a jour des lignes
    Can J Psychiatry. 2024;69:641-687.
    >> Share

    July 2024
  42. THERRIEN F, Ward C, Chokka P, Habert J, et al
    Adjunctive Brexpiprazole for Patient Life Engagement in Major Depressive Disorder: A Canadian, Phase 4, Open-Label, Interventional Study: Brexpiprazole d'appoint pour l'engagement dans la vie des patients souffrant de trouble depressif majeur: une etu
    Can J Psychiatry. 2024;69:513-523.
    >> Share

  43. MOINUL D, Hao C, Dimitropoulos G, Taylor VH, et al
    Patient Perceptions of Microbiome-Based Therapies as Novel Treatments for Mood Disorders: A Mixed Methods Study: Perceptions des patients sur les therapies basees sur le microbiome pour les troubles de l'humeur : une etude a methodes mixtes.
    Can J Psychiatry. 2024;69:503-512.
    >> Share

    June 2024
  44. CHEN Y, Zhao J, Wang J, Peng L, et al
    Effect of Bright Light Therapy on Perinatal Depression: A Systematic Review and Meta-Analysis: Effet de la luminotherapie sur la depression perinatale: une revue systematique et une meta-analyse.
    Can J Psychiatry. 2024 Jun 11:7067437241248051. doi: 10.1177/07067437241248051.
    >> Share

    May 2024
  45. WONG M, Kiss A, Herrmann N, Lanctot KL, et al
    Modifiable Risk Factors Associated With Cognitive Decline in Late Life Depression: Findings From the Canadian Longitudinal Study on Aging: Facteurs de risque modifiables associes au declin cognitif dans la depression en fin de vie : constatations de l
    Can J Psychiatry. 2024 May 15:7067437241255095. doi: 10.1177/07067437241255095.
    >> Share

    April 2024
  46. SCHELL C, Quilty LC, Cunningham JA
    Investigating Alexithymia as a Moderator of Outcomes in a Randomized Controlled Trial of an Online Intervention for Co-Occurring Depression and Hazardous Alcohol Use: Enquete sur l'alexithymie en tant que moderateur des resultats dans un essai randomi
    Can J Psychiatry. 2024 Apr 29:7067437241249412. doi: 10.1177/07067437241249412.
    >> Share

  47. BERK M, Agustini B, Forbes M, Jacka FN, et al
    Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023: Towards Personalized Approaches to Depression Treatment.
    Can J Psychiatry. 2024 Apr 22:7067437241248087. doi: 10.1177/07067437241248087.
    >> Share

  48. LI VW, Sahota J, Dev DK, Gill DD, et al
    A Randomized Evaluation of MoodFX, a Patient-Centred e-Health Tool to Support Outcome Measurement for Depression: Une evaluation randomisee de MoodFX, un outil de sante en ligne centre sur le patient pour soutenir la mesure du resultat dans la depress
    Can J Psychiatry. 2024 Apr 11:7067437241245331. doi: 10.1177/07067437241245331.
    >> Share

  49. WANG T, Gao C, Li J, Li L, et al
    Prediction of Early Antidepressant Efficacy in Patients with Major Depressive Disorder Based on Multidimensional Features of rs-fMRI and P11 Gene DNA Methylation: Prediction de l'efficacite precoce d'un antidepresseur chez des patients souffrant du tr
    Can J Psychiatry. 2024;69:264-274.
    >> Share

    February 2024
  50. JALALI S, Liu L, Wang J, Kennedy SH, et al
    Factors Associated with Transition to Serious Mental Illness.
    Can J Psychiatry. 2024;69:79-88.
    >> Share

  51. LAPOSA JM, Cameron D, Corace K, Quick N, et al
    A Rapid Access Brief Psychotherapy Intervention to Respond to Healthcare Workers in Ontario Whose Mental Health was Negatively Impacted During the COVID-19 Pandemic.
    Can J Psychiatry. 2024;69:89-99.
    >> Share

    December 2023
  52. LAI KSP, Waxman R, Blumberger DM, Giacobbe P, et al
    Competencies for Repetitive Transcranial Magnetic Stimulation in Postgraduate Medical Education: Expert Consensus Using a Modified Delphi Process.
    Can J Psychiatry. 2023;68:916-924.
    >> Share

    November 2023
  53. KHAN I, Chawla N
    Comments on "A Collaborative-Care Telephone-Based Intervention for Depression, Anxiety, and at-Risk Drinking in Primary Care: The PARTNERs Randomized Clinical Trial".
    Can J Psychiatry. 2023 Nov 22:7067437231216175. doi: 10.1177/07067437231216175.
    >> Share

  54. PINTO JV, Crippa JAS, Cereser KM, Vianna-Sulzbach MF, et al
    Cannabidiol as an Adjunctive Treatment for Acute Bipolar Depression: A Pilot Study.
    Can J Psychiatry. 2023 Nov 3:7067437231209650. doi: 10.1177/07067437231209650.
    >> Share

    October 2023
  55. ISLAM F, Magarbeh L, Elsheikh SSM, Kloiber S, et al
    Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study.
    Can J Psychiatry. 2023 Oct 5:7067437231203433. doi: 10.1177/07067437231203433.
    >> Share

    September 2023
  56. ANDREWS KL, Jamshidi L, Nisbet J, Brunet A, et al
    Potentially Psychologically Traumatic Event Exposure Histories of new Royal Canadian Mounted Police Cadets.
    Can J Psychiatry. 2023;68:663-681.
    >> Share

    August 2023
  57. BASTIEN G, McAnulty C, Ledjiar O, Socias ME, et al
    Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial.
    Can J Psychiatry. 2023;68:572-585.
    >> Share

    May 2023
  58. TOURJMAN SV, Buck G, Jutras-Aswad D, Khullar A, et al
    Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder.
    Can J Psychiatry. 2023;68:299-311.
    >> Share

    April 2023
  59. ADHIKARI K, Racine N, Hetherington E, McDonald S, et al
    Women's Mental Health up to Eight Years after Childbirth and Associated Risk Factors: Longitudinal Findings from the All Our Families Cohort in Canada.
    Can J Psychiatry. 2023;68:269-282.
    >> Share

  60. WOOD-ROSS C, Tran T, Milanovic M, Jokic R, et al
    Neurocognition and Depressive Symptoms have Unique Pathways to Predicting Different Domains of Functioning in Major Depressive Disorder.
    Can J Psychiatry. 2023;68:241-248.
    >> Share

    February 2023
  61. ISHRAT HUSAIN M, Rodie DJ, Perivolaris A, Sanches M, et al
    A Collaborative-Care Telephone-Based Intervention for Depression, Anxiety, and at-Risk Drinking in Primary Care: The PARTNERs Randomized Clinical Trial.
    Can J Psychiatry. 2023 Feb 28:7067437231156243. doi: 10.1177/07067437231156243.
    >> Share

    January 2023
  62. GREEN JE, Berk M, Mohebbi M, Loughman A, et al
    Feasibility, Acceptability, and Safety of Faecal Microbiota Transplantation in the Treatment of Major Depressive Disorder: A Pilot Randomized Controlled Trial.
    Can J Psychiatry. 2023 Jan 13:7067437221150508. doi: 10.1177/07067437221150508.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016